Loading
Life sciences · Journal article
Charakh Shastra the Mega Journal of Medicine · July 27, 2026
A consensus or society position rather than new primary data.
This is a narrative review and systems-oriented analysis proposing a five-point intervention roadmap for community pharmacists to combat antibiotic resistance in developing countries. The paper synthesizes the recognized role of pharmacists as accessible first-contact healthcare providers and proposes feasible strategies spanning patient education, dispensing accountability, symptom-based triage, digital adherence tools, and integrated collaboration with clinicians, without presenting original empirical evidence or outcome data.
Narrative review and systems-oriented analysis. Developing countries with high infectious disease burden and limited physician access; populations dependent on community pharmacy as first healthcare contact. Intervention: Five-point intervention roadmap: pharmacy-led patient education, dispensing accountability and prescription verification, symptom-based triage with safe referral, digital adherence and start/stop reminders, integrated pharmacist–clinician….
Community pharmacists are identified as the first point of contact and most accessible healthcare professionals for many populations in developing countries Irrational antibiotic consumption—including unnecessary use, incomplete courses, incorrect dosing, and use for viral illnesses—creates strong selection pressure for resistant microorganisms Five-point intervention roadmap proposed: (i) pharmacy-led patient education and expectation management, (ii) dispensing accountability and prescription verification, (iii) symptom-based triage with safe referral, (iv) digital adherence and start/stop reminders, (v) integrated collaboration between pharmacists and healthcare providers
Community pharmacists are identified as the first point of contact and most accessible healthcare professionals for many populations in developing countries Five-point intervention roadmap proposed: (i) pharmacy-led patient education and expectation management, (ii) dispensing accountability and prescription verification, (iii) symptom-based triage with safe referral, (iv) digital adherence and start/stop reminders, (v) integrated collaboration between pharmacists and healthcare providers
Healthcare professionals and policymakers in developing countries should consider integrating community pharmacists into antimicrobial stewardship frameworks through structured training, infrastructure investment, and collaborative protocols with clinicians. The proposed roadmap offers a systems-level approach to reduce inappropriate antibiotic use where physician access is limited and pharmacist accessibility is high.
This is a narrative review and systems-oriented analysis proposing a feasible intervention roadmap for pharmacist roles in combating antibiotic resistance in developing countries, based on expert assessment rather than empirical trial data.
As stated by the source record.
Healthcare professionals and policymakers in developing countries should consider integrating community pharmacists into antimicrobial stewardship frameworks through structured training, infrastructure investment, and collaborative protocols with clinicians. The proposed roadmap offers a systems-level approach to reduce inappropriate antibiotic use where physician access is limited and pharmacist accessibility is high.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Antibiotic resistance is increasingly recognized as a “new war” for global health, particularly in developing countries where health systems face high infectious disease burden, limited access to physicians, and widespread non-prescription medicine use. With a limited number of effective antibiotics available and comparatively slow discovery of new agents, irrational antibiotic consumption—especially unnecessary use, incomplete courses, incorrect dosing, and use for viral illnesses—creates strong selection pressure for resistant microorganisms. The World Health Organization (WHO) identifies antimicrobial resistance (AMR) as a top global public health and development threat and emphasizes that misuse and overuse of antimicrobials in human health, animals, and agriculture are key drivers. (World Health Organization) Community pharmacists occupy a crucial position in developing countries as the first point of contact and the most accessible healthcare professionals for many populations. This paper examines the role and responsibility of pharmacists in combating antibiotic resistance by addressing over-the-counter (OTC) antibiotic sales, improving patient education, discouraging antibiotic use for viral infections, supporting appropriate referral pathways, and collaborating with clinicians and health systems to establish unified stewardship frameworks. Using a narrative review and systems-oriented analysis, this article proposes a feasible intervention roadmap: (i) pharmacy-led patient education and expectation management, (ii) dispensing accountability and prescription verification, (iii) symptom-based triage with safe referral, (iv) digital adherence and start/stop reminders, and (v) integrated collaboration between pharmacists and healthcare providers to standardize guideline-based antibiotic use. Strengthening pharmacist training, infrastructure, and recognition is argued to be essential for sustainable AMR control.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.